Limits...
Intravascular papillary endothelial hyperplasia: histomorphological and immunohistochemical features.

Akdur NC, Donmez M, Gozel S, Ustun H, Hucumenoglu S - Diagn Pathol (2013)

Bottom Line: Staining for the other vascular markers (FVIII, type IV collagen, SMA and MSA) was variable.In our opinion, the evaluation of immune markers in a larger sample set will reveal new features in the maturity and developmental pathogenesis of vascular lesions and angiogenesis.IPEH is a benign lesion, which must be differentiated from malignant tumors such as angiosarcoma and Kaposi's sarcoma.

View Article: PubMed Central - HTML - PubMed

Affiliation: Pathology Department, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey. mdonmezm@gmail.com.

ABSTRACT

Background: Intravascular papillary endothelial hyperplasia (IPEH) is a benign intravascular process with features mimicking other benign and malignant vascular proliferations. IPEH lesions predominate in the head-neck region and the extremities. The characteristic histomorphological feature of IPEH is a papillary structure covered with hyperplastic endothelial cells within the vascular lumen. It is critical that this clinically benign lesion should not be mistaken for well-differentiated vascular tumors. In addition to the characteristic histological features, other useful diagnostic features included the intra-luminal location of the lesion, an intimate association with the organizing thrombus, the absence of necrosis, cellular pleomorphism, and mitotic activity. In addition, immunohistochemistry may indicate the vascular origin and proliferative index. In this study, we evaluated histomorphological and immunohistochemical findings (CD31, CD34, FVIII, type IV collagen, SMA, MSA, CD105, and Ki-67 staining) of ten IPEH cases.

Methods: Ten IPEH cases were re-examined for a panel of histomorphological and immunohistochemical features. CD31, CD34, FVIII, Type IV collagen, SMA and MSA antibodies utilized for immunohistochemical analysis.The histomorphological and immunohistochemical findings were evaluated by two independent pathologists using light microscopy.

Results: All ten cases involved intraluminal lesions with characteristic features of IPEH. All ten cases (100%) were stained positive for CD31 and CD34. The degree of staining with FVIII, type IV collagen, SMA, and MSA was variable.

Conclusion: In this series of specimens, CD31 and CD34 were the most sensitive markers indicating the vascular origin of the lesion. Staining for the other vascular markers (FVIII, type IV collagen, SMA and MSA) was variable. Different maturation degrees of lesions may account for the variation in immunohistochemical staining. Few previous investigations evaluated a wide range of antigen panels in IPEH sections. In our opinion, the evaluation of immune markers in a larger sample set will reveal new features in the maturity and developmental pathogenesis of vascular lesions and angiogenesis. IPEH is a benign lesion, which must be differentiated from malignant tumors such as angiosarcoma and Kaposi's sarcoma. Improved definition of IPEH lesions using immunohistochemical markers may enhance the ability to differentiate between various vascular lesions.

Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1381849312101856.

Show MeSH

Related in: MedlinePlus

Endothelial cells stained with CD31 (×400).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4016006&req=5

Figure 6: Endothelial cells stained with CD31 (×400).

Mentions: The immunohistochemical staining distribution is shown in Table 2. In 5 cases (50%); CD31, CD34, FVIII, Type 4 collagen, SMA and MSA markers was observed as positive. The remaining cases demonstrated variable staining for these markers. Staining by CD31 and CD34 was present in all 10 cases (100%) (Figures 5 and 6) while staining by FVIII was observed in 6 cases (60%). Type 4 collagen staining was present in 8 cases (80%). SMA and MSA co-staining occurred in 8 cases, with only 2 cases (20%) having no reactivity for these immune markers. None of the cases stained positive for CD105. The proliferative index was less than 8% (1%-8%) for the cases examined.


Intravascular papillary endothelial hyperplasia: histomorphological and immunohistochemical features.

Akdur NC, Donmez M, Gozel S, Ustun H, Hucumenoglu S - Diagn Pathol (2013)

Endothelial cells stained with CD31 (×400).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4016006&req=5

Figure 6: Endothelial cells stained with CD31 (×400).
Mentions: The immunohistochemical staining distribution is shown in Table 2. In 5 cases (50%); CD31, CD34, FVIII, Type 4 collagen, SMA and MSA markers was observed as positive. The remaining cases demonstrated variable staining for these markers. Staining by CD31 and CD34 was present in all 10 cases (100%) (Figures 5 and 6) while staining by FVIII was observed in 6 cases (60%). Type 4 collagen staining was present in 8 cases (80%). SMA and MSA co-staining occurred in 8 cases, with only 2 cases (20%) having no reactivity for these immune markers. None of the cases stained positive for CD105. The proliferative index was less than 8% (1%-8%) for the cases examined.

Bottom Line: Staining for the other vascular markers (FVIII, type IV collagen, SMA and MSA) was variable.In our opinion, the evaluation of immune markers in a larger sample set will reveal new features in the maturity and developmental pathogenesis of vascular lesions and angiogenesis.IPEH is a benign lesion, which must be differentiated from malignant tumors such as angiosarcoma and Kaposi's sarcoma.

View Article: PubMed Central - HTML - PubMed

Affiliation: Pathology Department, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey. mdonmezm@gmail.com.

ABSTRACT

Background: Intravascular papillary endothelial hyperplasia (IPEH) is a benign intravascular process with features mimicking other benign and malignant vascular proliferations. IPEH lesions predominate in the head-neck region and the extremities. The characteristic histomorphological feature of IPEH is a papillary structure covered with hyperplastic endothelial cells within the vascular lumen. It is critical that this clinically benign lesion should not be mistaken for well-differentiated vascular tumors. In addition to the characteristic histological features, other useful diagnostic features included the intra-luminal location of the lesion, an intimate association with the organizing thrombus, the absence of necrosis, cellular pleomorphism, and mitotic activity. In addition, immunohistochemistry may indicate the vascular origin and proliferative index. In this study, we evaluated histomorphological and immunohistochemical findings (CD31, CD34, FVIII, type IV collagen, SMA, MSA, CD105, and Ki-67 staining) of ten IPEH cases.

Methods: Ten IPEH cases were re-examined for a panel of histomorphological and immunohistochemical features. CD31, CD34, FVIII, Type IV collagen, SMA and MSA antibodies utilized for immunohistochemical analysis.The histomorphological and immunohistochemical findings were evaluated by two independent pathologists using light microscopy.

Results: All ten cases involved intraluminal lesions with characteristic features of IPEH. All ten cases (100%) were stained positive for CD31 and CD34. The degree of staining with FVIII, type IV collagen, SMA, and MSA was variable.

Conclusion: In this series of specimens, CD31 and CD34 were the most sensitive markers indicating the vascular origin of the lesion. Staining for the other vascular markers (FVIII, type IV collagen, SMA and MSA) was variable. Different maturation degrees of lesions may account for the variation in immunohistochemical staining. Few previous investigations evaluated a wide range of antigen panels in IPEH sections. In our opinion, the evaluation of immune markers in a larger sample set will reveal new features in the maturity and developmental pathogenesis of vascular lesions and angiogenesis. IPEH is a benign lesion, which must be differentiated from malignant tumors such as angiosarcoma and Kaposi's sarcoma. Improved definition of IPEH lesions using immunohistochemical markers may enhance the ability to differentiate between various vascular lesions.

Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1381849312101856.

Show MeSH
Related in: MedlinePlus